Efficacy of Behavioral Insomnia Treatment for Chronic Migraine

This study is currently recruiting participants.
Verified June 2013 by University of Mississippi, Oxford
Sponsor:
Collaborators:
Migraine Research Foundation
The Oxford Neurology Clinic
Information provided by (Responsible Party):
Jennifer Caldwell, University of Mississippi, Oxford
ClinicalTrials.gov Identifier:
NCT01314651
First received: March 11, 2011
Last updated: June 17, 2013
Last verified: June 2013

March 11, 2011
June 17, 2013
March 2011
February 2014   (final data collection date for primary outcome measure)
Headache frequency [ Time Frame: 2 weeks post-treatment, 6 weeks post-treatment ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT01314651 on ClinicalTrials.gov Archive Site
  • Headache severity [ Time Frame: 2 weeks post-treatment, 6 weeks post-treatment ] [ Designated as safety issue: No ]
  • Headache-related disability [ Time Frame: 2 weeks post-treatment; 6 weeks post-treatment ] [ Designated as safety issue: No ]
  • Total Sleep Time [ Time Frame: 2 weeks post-treatment; 6 weeks post-treatment ] [ Designated as safety issue: No ]
Same as current
Not Provided
Not Provided
 
Efficacy of Behavioral Insomnia Treatment for Chronic Migraine
Efficacy of Behavioral Insomnia Treatment for Chronic Migraine: A Randomized Controlled Pilot Study

The purpose of this study is to test the efficacy of a brief behavioral insomnia intervention in reducing headache frequency and severity among patients with chronic migraine and insomnia. It is hypothesized that this intervention will produce greater changes in headache frequency and severity than will a comparison treatment involving non-sleep-specific general lifestyle modifications.

Chronic migraine (occurring 15 or more days per month) is a disabling disorder that engenders significant personal suffering and healthcare costs. Frequently, individuals with chronic migraine also suffer from symptoms of insomnia, the regulation of which has been shown to improve migraine. A variety of effective and well-validated behavioral treatments exist to reduce symptoms of insomnia but have not been widely applied to migraine patients. The goal of this study is to pilot test and compare the efficacy of 2 different behavioral (non-medication) treatments for chronic migraine, one of which addresses insomnia symptoms and one of which addresses general lifestyle changes, on headache and sleep parameters. Patients will be adults (18-65) diagnosed with chronic migraine and insomnia at the Oxford Neurology Clinic when they present for routine medical appointments. They will be maintained on usual medical care and referred to the Psychological Services Center for collection of baseline data and administration of the behavioral interventions. At baseline participants will be administered a structured interview and questionnaires pertaining to headache symptoms, sleep problems, and depression/anxiety. They will keep a daily diary of headache variables for 2 weeks and wear an actigraph on their wrist during baseline. Patients will be randomly assigned to receive either the a treatment focused on modifying general lifestyle behaviors (Lifestyle Modification; a replication of the instructions from Calhoun and Ford, 2007) or making changes to their sleep behaviors (Sleep Management) for 3 brief (20-30 min) sessions, spaced 2 weeks apart. Treatments will entail education/rationale about the intervention and a review of a set of instructions unique to each condition. Subsequent sessions will ensure compliance with the respective instructions. Daily monitoring of headache symptoms will continue throughout the trial. Participants will complete the aforementioned questionnaires at 2 posttreatment follow-up visits and wear the actigraph again for 2 week periods surrounding the 2 follow-up visits.

Interventional
Not Provided
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
  • Chronic Migraine
  • Insomnia
  • Behavioral: Stimulus Control and Sleep Restriction
    5 instructions in stimulus control and individually-tailored sleep restriction
  • Behavioral: Lifestyle Modification
    5 instructions in changing general lifestyle habits (maintaining consistent liquid intake, range of motion exercises, eating a serving of protein in the morning, etc.)
  • Experimental: Sleep Management
    Instructions in stimulus control and sleep restriction.
    Intervention: Behavioral: Stimulus Control and Sleep Restriction
  • Sham Comparator: Lifestyle Modification
    Instructions to change general lifestyle habits (maintain consistent liquid consumption, range of motion exercises, etc.)
    Intervention: Behavioral: Lifestyle Modification
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
50
February 2014
February 2014   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Adult patients aged 18-65 diagnosed with chronic migraine (15 or more days with headache per month, most of which must be migraine) and insomnia who present for routine medical care for migraine.

Exclusion Criteria:

  • Currently pregnant or breastfeeding, being unable to read or speak English at a 6th grade level, alcohol or substance abuse or dependence, bipolar disorder or seizure disorder, psychiatric hospitalization within the last year, medication overuse headache, and patients not stable on current migraine medications.
Both
18 Years to 65 Years
No
Contact: Todd A Smitherman, Ph.D. 662-915-1832 tasmithe@olemiss.edu
United States
 
NCT01314651
UMO-0002
No
Jennifer Caldwell, University of Mississippi, Oxford
University of Mississippi, Oxford
  • Migraine Research Foundation
  • The Oxford Neurology Clinic
Principal Investigator: Todd A Smitherman, Ph.D. University of Mississippi Medical Center
University of Mississippi, Oxford
June 2013

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP